Journal of Neuromuscular Diseases

Scope & Guideline

Exploring the frontiers of neurology and muscle disorders.

Introduction

Welcome to the Journal of Neuromuscular Diseases information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Journal of Neuromuscular Diseases, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2214-3599
PublisherIOS PRESS
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2014 to 2024
AbbreviationJ NEUROMUSCULAR DIS / J. Neuromusc. Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressNIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS

Aims and Scopes

The Journal of Neuromuscular Diseases serves as a pivotal platform for advancing knowledge in the field of neuromuscular disorders, focusing on both clinical and translational research. It aims to publish high-quality studies that contribute to the understanding, diagnosis, treatment, and management of neuromuscular diseases.
  1. Clinical Research and Trials:
    The journal emphasizes clinical studies and trials related to various neuromuscular diseases, particularly focusing on treatment efficacy, safety, and patient outcomes.
  2. Genetic and Molecular Insights:
    Research articles exploring genetic variants, molecular mechanisms, and biochemical pathways associated with neuromuscular diseases are a core focus, enhancing the understanding of disease pathogenesis.
  3. Patient-Centered Outcomes:
    There is a strong emphasis on patient-reported outcomes and quality of life assessments, which inform clinical practice and patient management strategies.
  4. Innovative Therapeutics:
    The journal features studies on emerging therapeutic approaches, including gene therapy, oligonucleotide therapies, and novel pharmacological treatments for neuromuscular disorders.
  5. Multidisciplinary Approaches:
    It promotes a multidisciplinary approach, integrating perspectives from neurology, genetics, rehabilitation, and psychosocial aspects to address the complexities of neuromuscular diseases.
  6. Technological Advancements:
    Research on innovative diagnostic and therapeutic technologies, such as wearable devices and imaging techniques, is a key area of interest, aiming to improve patient care and monitoring.
The Journal of Neuromuscular Diseases has shown a dynamic evolution in its thematic focus, reflecting emerging trends in the field of neuromuscular research. This section delineates the key themes gaining traction, highlighting their significance for future research directions.
  1. Gene Therapy and Precision Medicine:
    There is an increasing emphasis on gene therapy approaches, particularly for conditions like Duchenne muscular dystrophy and spinal muscular atrophy, indicating a trend towards personalized treatment strategies.
  2. Longitudinal Studies and Natural History Research:
    Recent publications demonstrate a growing interest in longitudinal studies that track disease progression and natural history, providing valuable insights into the long-term impacts of neuromuscular disorders and treatment outcomes.
  3. Wearable Technology and Digital Health:
    The integration of wearable devices for monitoring patient health and activity levels is emerging as a significant theme, reflecting a shift towards digital health solutions in managing neuromuscular diseases.
  4. Patient-Centric Research and Quality of Life:
    Research focusing on patient experiences, quality of life, and psychosocial factors is gaining prominence, underscoring the importance of holistic approaches to treatment and care in neuromuscular disorders.
  5. Multimodal Therapeutic Approaches:
    There is a trend towards exploring multimodal therapeutic strategies that combine pharmacological treatments, physical rehabilitation, and psychosocial support, aiming for comprehensive patient care.

Declining or Waning

While the Journal of Neuromuscular Diseases continues to expand its horizons, certain themes appear to be declining in prominence based on recent publication trends. This section highlights areas that may require renewed focus or innovative approaches to enhance their relevance in current research.
  1. Traditional Diagnostic Methods:
    There has been a notable shift away from reliance on traditional diagnostic methods in favor of more advanced genetic testing and imaging techniques, leading to fewer publications focused solely on conventional diagnostics.
  2. Basic Science Studies:
    Research articles centered on purely basic science without direct clinical implications seem to be less frequent, as the journal increasingly prioritizes translational research that connects laboratory findings with clinical applications.
  3. Generalized Neuromuscular Disorders:
    Publications discussing generalized or non-specific neuromuscular disorders are becoming less common, as the journal focuses more on specific conditions, such as Duchenne muscular dystrophy and spinal muscular atrophy.

Similar Journals

Hematology

Unlocking Potential: Pioneering Research in Blood Disorders
Publisher: TAYLOR & FRANCIS LTDISSN: 1024-5332Frequency: 1 issue/year

Hematology is a distinguished open-access journal published by Taylor & Francis Ltd, dedicated to advancing research and knowledge in the field of hematology. Established in 1996, the journal has continually evolved to meet the needs of a growing community of researchers and practitioners, providing a vital platform for disseminating innovative findings and clinical insights. With its impact factor reflecting a robust commitment to quality scholarship, Hematology has achieved a respectable position in its category as evidenced by its Q3 ranking in the Hematology category and ranks #85 out of 137 in the Scopus index, which positions it in the 38th percentile among its peers. The journal’s open-access policy, initiated in 2019, further enhances its reach and accessibility, allowing a broad audience of professionals, researchers, and students to engage with high-quality research without barriers. By covering a wide range of topics related to blood disorders, treatment methodologies, and emerging therapies, Hematology stands as an essential resource for those dedicated to innovation in this critical area of healthcare.

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Advancing Dermatological Knowledge Since 1977
Publisher: MASSON EDITEURISSN: 0151-9638Frequency: 12 issues/year

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE is a distinguished journal that serves as a vital platform for disseminating innovative research and insightful reviews in the field of dermatology and venereology. Published by MASSON EDITEUR, this journal has been a cornerstone for professionals and researchers since its inception in 1977, offering a wealth of knowledge that spans decades. With its ISSN 0151-9638 and E-ISSN 2214-5451, it is indexed within leading databases, ensuring that the published work reaches a broad audience. The journal currently holds a Q3 ranking in the dermatology category, reflecting its commitment to quality and rigorous peer-review processes. While the journal is not open access, it provides an extensive archive of valuable studies that contribute to advancements in skin health and treatment methodologies. Located in Issy-les-Moulineaux, France, ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE continues to attract submissions from esteemed professionals, enhancing its reputation as a crucial resource for those dedicated to the ongoing development of dermatological sciences.

ARCHIVES OF MEDICAL RESEARCH

Empowering healthcare innovation with cutting-edge studies.
Publisher: ELSEVIER SCIENCE INCISSN: 0188-4409Frequency: 8 issues/year

Archives of Medical Research is a prestigious scholarly journal dedicated to advancing the field of medicine through the dissemination of high-quality research findings. Published by Elsevier Science Inc., this esteemed journal has garnered significant recognition, boasting a remarkable impact factor and ranking in the top quartile (Q1) of its category, specifically in General Medicine with a Scopus rank of #30 out of 636 journals, placing it in the 95th percentile. Since its inception in 1992, Archives of Medical Research has served as a critical platform for researchers and professionals to share innovative insights and empirical studies that address pressing medical issues and enhance clinical practices. The journal welcomes a range of submissions, ensuring a diverse array of topics that reflect the latest trends and developments in medicine. As the journal continues to push the boundaries of medical research until at least 2025, it remains an essential resource for students, academics, and healthcare professionals striving to make a meaningful impact in the medical community.

Blood Advances

Transforming Knowledge into Clinical Practice
Publisher: ELSEVIERISSN: 2473-9529Frequency: 24 issues/year

Blood Advances is a premier, peer-reviewed journal published by Elsevier, dedicated to the field of hematology. With an impressive impact factor and classified within the Q1 category of hematology for 2023, it ranks as the 16th out of 137 journals in the Scopus Medicine Hematology category, placing it in the top 88th percentile globally. This influential journal, which has been disseminating invaluable research since its inception in 2017, focuses on advancing knowledge and innovation in blood science, including clinical and laboratory aspects of hematology. Although it offers limited open access features, its comprehensive scope encompasses various topics relevant to both researchers and practitioners. Located in the United States and managed from Amsterdam, Blood Advances provides a vital platform for the dissemination of groundbreaking research, making significant contributions to the understanding and treatment of blood disorders. Researchers, professionals, and students alike will find this journal an essential resource for keeping abreast of the latest developments and advancements in hematology.

CLINICAL AND EXPERIMENTAL MEDICINE

Unlocking the Future of Medicine Through Collaboration
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 1591-8890Frequency: 4 issues/year

Clinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.

Pulmonary Circulation

Elevating the discourse in pulmonary and respiratory medicine.
Publisher: WILEYISSN: 2045-8932Frequency: 4 issues/year

Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.

Translational Gastroenterology and Hepatology

Fostering Global Collaboration in Gastrointestinal Science.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

CURRENT OPINION IN NEUROLOGY

Navigating the Evolving Landscape of Neurology.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1350-7540Frequency: 6 issues/year

CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.

Annals of Dermatology

Exploring breakthroughs in dermatological research.
Publisher: KOREAN DERMATOLOGICAL ASSOCISSN: 1013-9087Frequency: 6 issues/year

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.

Orphanet Journal of Rare Diseases

Fostering collaboration in the rare disease community.
Publisher: BMCISSN: Frequency: 1 issue/year

The Orphanet Journal of Rare Diseases, published by BMC since 2006, serves as a vital platform for the dissemination of groundbreaking research in the realm of rare diseases. With a notable Q1 ranking in both the Medicine (miscellaneous) and Pharmacology (medical) categories, and a respectable Q2 ranking in Genetics (clinical), the journal is recognized for its impactful contributions, evidenced by its position in the top quartiles of Scopus rankings. This open-access journal allows unrestricted access to its content, promoting a global exchange of knowledge among researchers, healthcare professionals, and academics. By covering a broad spectrum of rare diseases, the Orphanet Journal aims to enhance awareness, improve diagnosis and treatment, and ultimately contribute to the improvement of patients' lives. With a commitment to high-quality research, this journal stands as an essential resource for anyone involved in the study or treatment of rare diseases.